Cover Image

Can diet and exercise intervention prevent type 2 diabetes in individuals with a high genetic risk?

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Iskandar Idris
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Diabetes, Obesity and Metabolism Now
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Appropriate timing of exercise for adults with obesity including those with type 2 diabetes
by: Iskandar Idris
Published: (2024)

Precision medicine approach to detect obese people who are at high risk of developing diabetes
by: Iskandar Idris
Published: (2024)

Extension study from DIRECT showed ongoing remission rate from type 2 diabetes in some patient following very low calorie diet at 5 years
by: Iskandar Idris
Published: (2024)

Epigenetic changes shown to cause type 2 diabetes
by: Iskandar Idris
Published: (2024)

Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
by: Iskandar Idris
Published: (2024)

Hybrid closed‐loop therapy significantly improved maternal glucose control during pregnancy complicated by type 1 diabetes
by: Iskandar Idris
Published: (2024)

Fenofibrate shown to reduce progression of diabetic retinopathy
by: Iskandar Idris
Published: (2024)

Adults who are overweight or obese may experience greater pain intensity compared with normal weight individuals?
by: Iskandar Idris
Published: (2024)

Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer?
by: Iskandar Idris
Published: (2024)

Real world study provided reassurance of the safety of GLP‐1 therapy on mental health and suicide risk
by: Iskandar Idris
Published: (2024)

Increasing excess to weight loss injection shown to save thousands of lives a year
by: Iskandar Idris
Published: (2024)

The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy
by: Iskandar Idris
Published: (2024)

Tirzepatide shown to be effective at reducing sleep disturbances in patients with obstructive sleep apnoea
by: Iskandar Idris
Published: (2024)

Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity
by: Iskandar Idris
Published: (2024)

The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
by: Iskandar Idris
Published: (2024)

Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied
by: Iskandar Idris
Published: (2024)

Real world data showed that the dual GLP gip agonist, Tirzepatide is associated with lower mortality, cardiovascular events and adverse kidney events compared with GLP‐1 analogue
by: Iskandar Idris
Published: (2024)

Increased expression of the protein Kallistatin after weight loss induces beneficial metabolic effects: A potential new therapeutic target?
by: Iskandar Idris
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
by: Iskandar Idris, et al.
Published: (2025)

Sex as a modifier of genetic risk for type 1 diabetes
by: Hui‐Qi Qu, et al.
Published: (2025)

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
by: Filipe A. Moura, et al.
Published: (2024)

Genomic risk prediction for type 2 diabetes in Australian individuals aged 70 years and older
by: Chenglong Yu, et al.
Published: (2025)

Effect of exercise on plasma insulin levels in individuals with type 1 diabetes: A systematic review and meta‐analysis
by: Lum Kastrati, et al.
Published: (2024)

Efficacy of a low‐carbohydrate diet combined with exercise on glycemic control and metabolic health in type 2 diabetes mellitus: A systematic review and meta‐analysis
by: Ye He, et al.
Published: (2025)

Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting
by: Abdullah M. Alguwaihes, et al.
Published: (2025)

Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
by: Djordje S. Popovic, et al.
Published: (2024)

Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank
by: Ying Hu, et al.
Published: (2024)

Postnatal glycaemic outcomes in women with high‐risk gestational diabetes: Identifying key predictors for early intervention
by: Pei Chia Eng, et al.
Published: (2024)

Cognitive reserve, genetic risk, and lifestyle in the incidence and progression of type 2 diabetes: A large community‐based longitudinal study
by: Shaojie Han, et al.
Published: (2025)

Association between accelerometer‐measured physical activity, genetic risk, and incident type 2 diabetes: A prospective cohort study
by: Yang Pan, et al.
Published: (2025)

Effect of spironolactone wash‐out on albuminuria after long‐term treatment in individuals with type 2 diabetes and high risk of kidney disease—An observational follow‐up of the PRIORITY study
by: Victor Wasehuus, et al.
Published: (2024)

Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model
by: Marga A. G. Helmink, et al.
Published: (2024)